Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
Extended trial tests if new hives drug keeps working Long-Term
Disease control Recruiting nowThis study is for adults with chronic spontaneous urticaria (CSU), also known as chronic hives, who have already completed one of two earlier Phase 3 trials for the drug barzolvolimab. The main goal is to collect long-term data on how well the drug continues to control hives and …
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First test of new asthma antibody begins
Disease control Recruiting nowThis is a very early, first-in-human study to see if a new drug called CDX-622 is safe for people with mild to moderate asthma. Twelve participants will receive one dose via an IV infusion and be followed for 12 weeks. The main goal is to check for side effects and see how the dr…
Phase: PHASE1 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug trial targets uncontrollable skin reactions to cold and touch
Disease control Recruiting nowThis study is testing an investigational drug called barzolvolimab for adults whose skin breaks out in itchy hives from cold temperatures or light scratching, even while taking standard allergy medications. About 240 participants will receive either the drug or a placebo injectio…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC